Martin Fassnacht
#123,384
Most Influential Person Now
Researcher, ORCID id # 0000-0001-6170-6398
Martin Fassnacht's AcademicInfluence.com Rankings
Martin Fassnachtcomputer-science Degrees
Computer Science
#5063
World Rank
#5349
Historical Rank
Computational Linguistics
#616
World Rank
#628
Historical Rank
Machine Learning
#1199
World Rank
#1219
Historical Rank
Artificial Intelligence
#1431
World Rank
#1460
Historical Rank
Download Badge
Computer Science
Martin Fassnacht's Degrees
- PhD Computer Science Stanford University
- Masters Computer Science Stanford University
- Bachelors Computer Science University of California, Berkeley
Similar Degrees You Can Earn
Why Is Martin Fassnacht Influential?
(Suggest an Edit or Addition)Martin Fassnacht's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Oncogenic Signaling Pathways in The Cancer Genome Atlas (2018) (1646)
- Comprehensive Characterization of Cancer Driver Genes and Mutations (2018) (1360)
- Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. (2016) (982)
- Clinical review: Adrenocortical carcinoma: clinical update. (2006) (676)
- Adjuvant mitotane treatment for adrenocortical carcinoma. (2007) (544)
- Integrated genomic characterization of adrenocortical carcinoma (2014) (519)
- Pathogenic Germline Variants in 10,389 Adult Cancers (2018) (501)
- Service Orientation of a Retailer's Business Strategy: Dimensions, Antecedents, and Performance Outcomes (2002) (485)
- Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients (2018) (471)
- Quality of Electronic Services (2006) (436)
- Mutations in the deubiquitinase gene USP8 cause Cushing's disease (2014) (412)
- Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma (2009) (409)
- Adrenocortical carcinoma: a clinician's update (2011) (349)
- Update in adrenocortical carcinoma. (2013) (332)
- Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome. (2014) (320)
- European Society of Endocrinology Clinical Practice Guidelines on the Management of Adrenocortical Carcinoma in Adults, in collaboration with the European Network for the Study of Adrenal Tumors. (2018) (319)
- Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal Tumors (2011) (307)
- European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma. (2016) (306)
- Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. (2016) (295)
- Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2012) (288)
- Clinical management of adrenocortical carcinoma. (2009) (288)
- Combination chemotherapy in advanced adrenocortical carcinoma. (2012) (275)
- Epidemiology of adrenal crisis in chronic adrenal insufficiency: the need for new prevention strategies. (2010) (273)
- High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: a prospective study. (2015) (272)
- Impaired subjective health status in 256 patients with adrenal insufficiency on standard therapy based on cross-sectional analysis. (2007) (250)
- Laparoscopic versus open adrenalectomy for adrenocortical carcinoma: surgical and oncologic outcome in 152 patients. (2010) (247)
- Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection. (2015) (244)
- Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. (2016) (241)
- Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study. (2015) (238)
- High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors. (2010) (207)
- Efficacy of adjuvant radiotherapy of the tumor bed on local recurrence of adrenocortical carcinoma. (2006) (205)
- Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context (2018) (188)
- The Role of Soft Factors in Implementing a Service-Oriented Strategy in Industrial Marketing Companies (2003) (183)
- Frequent incidental discovery of phaeochromocytoma: data from a German cohort of 201 phaeochromocytoma. (2009) (174)
- Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study. (2015) (172)
- European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors (2018) (167)
- Radiotherapy in adrenocortical carcinoma (2009) (164)
- Genome-wide copy number variation analysis in attention-deficit/hyperactivity disorder: association with neuropeptide Y gene dosage in an extended pedigree (2011) (160)
- Clinical Predictors and Algorithm for the Genetic Diagnosis of Pheochromocytoma Patients (2009) (159)
- Plasma concentrations of o,p'DDD, o,p'DDA, and o,p'DDE as predictors of tumor response to mitotane in adrenocortical carcinoma: results of a retrospective ENS@T multicenter study. (2011) (159)
- Vaccination against the forkhead family transcription factor Foxp3 enhances tumor immunity. (2007) (152)
- Dehydroepiandrosterone supplementation in healthy men with an age-related decline of dehydroepiandrosterone secretion. (2001) (145)
- Mitotane Inhibits Sterol-O-Acyl Transferase 1 Triggering Lipid-Mediated Endoplasmic Reticulum Stress and Apoptosis in Adrenocortical Carcinoma Cells. (2015) (145)
- Tumor immunotherapy targeting fibroblast activation protein, a product expressed in tumor-associated fibroblasts. (2005) (144)
- Mitotane for adrenocortical carcinoma treatment. (2005) (143)
- Impact of Lymphadenectomy on the Oncologic Outcome of Patients With Adrenocortical Carcinoma (2012) (142)
- Consequences of Web-based service quality: Uncovering a multi-faceted chain of effects (2007) (141)
- Beyond adrenal and ovarian androgen generation: Increased peripheral 5 alpha-reductase activity in women with polycystic ovary syndrome. (2003) (141)
- Merits and pitfalls of mifepristone in Cushing's syndrome. (2009) (134)
- Uncovering Collaborative Value Creation Patterns and Establishing Corresponding Customer Roles (2013) (134)
- Sunitinib in refractory adrenocortical carcinoma: a phase II, single-arm, open-label trial. (2012) (132)
- β-Catenin Activation Is Associated with Specific Clinical and Pathologic Characteristics and a Poor Outcome in Adrenocortical Carcinoma (2010) (132)
- Treatment of advanced adrenocortical carcinoma with erlotinib plus gemcitabine. (2008) (131)
- Mitotane therapy in adrenocortical cancer induces CYP3A4 and inhibits 5α-reductase, explaining the need for personalized glucocorticoid and androgen replacement. (2013) (130)
- Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up†. (2020) (129)
- The role of surgery in the management of recurrent adrenocortical carcinoma. (2013) (128)
- Copeptin in the differential diagnosis of the polydipsia-polyuria syndrome--revisiting the direct and indirect water deprivation tests. (2011) (127)
- MANAGEMENT OF ENDOCRINE DISEASE: Imaging for the diagnosis of malignancy in incidentally discovered adrenal masses: a systematic review and meta-analysis (2016) (122)
- Adrenal tumors: How to establish malignancy? (2004) (120)
- Mitotane levels predict the outcome of patients with adrenocortical carcinoma treated adjuvantly following radical resection. (2013) (116)
- Adjuvant therapy in patients with adrenocortical carcinoma: a position of an international panel. (2010) (115)
- Congenital isolated adrenocorticotropin deficiency: an underestimated cause of neonatal death, explained by TPIT gene mutations. (2005) (115)
- Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10 (2011) (115)
- Adrenal incidentalomas: a manifestation of the metabolic syndrome? (1996) (114)
- Management of adrenocortical carcinoma (2004) (113)
- Bevacizumab plus capecitabine as a salvage therapy in advanced adrenocortical carcinoma. (2010) (111)
- Prognostic role of overt hypercortisolism in completely operated patients with adrenocortical cancer. (2014) (111)
- ACTH-receptor expression, regulation and role in adrenocortial tumor formation. (2001) (105)
- New targets and therapeutic approaches for endocrine malignancies. (2009) (101)
- Dehydroepiandrosterone replacement in women with adrenal insufficiency: effects on body composition, serum leptin, bone turnover, and exercise capacity. (2001) (101)
- Long-Term Outcomes of Adjuvant Mitotane Therapy in Patients With Radically Resected Adrenocortical Carcinoma (2017) (100)
- FATE1 antagonizes calcium‐ and drug‐induced apoptosis by uncoupling ER and mitochondria (2016) (98)
- Characteristics of Pediatric vs Adult Pheochromocytomas and Paragangliomas (2017) (98)
- Biochemical Diagnosis of Chromaffin Cell Tumors in Patients at High and Low Risk of Disease: Plasma versus Urinary Free or Deconjugated O-Methylated Catecholamine Metabolites. (2018) (97)
- Adrenal function after adrenalectomy for subclinical hypercortisolism and Cushing's syndrome: a systematic review of the literature. (2014) (95)
- TP53 germline mutations in adult patients with adrenocortical carcinoma. (2012) (95)
- Contemporary management of adrenocortical carcinoma. (2011) (94)
- Discerning malignancy in adrenocortical tumors: are molecular markers useful? (2001) (89)
- Novel somatic mutations in the catalytic subunit of the protein kinase A as a cause of adrenal Cushing's syndrome: a European multicentric study. (2014) (89)
- Relationship Marketing: Gaining Competitive Advantage Through Customer Satisfaction and Customer Retention (2017) (88)
- A Framework for Supplier Relationship Management (SRM) (2006) (88)
- Mitotane Monotherapy in Patients With Advanced Adrenocortical Carcinoma (2018) (87)
- Octreotide LAR® treatment throughout pregnancy in an acromegalic woman (2001) (86)
- Drug interactions with mitotane by induction of CYP3A4 metabolism in the clinical management of adrenocortical carcinoma (2011) (83)
- Potency and tolerance of calcitonin stimulation with high-dose calcium versus pentagastrin in normal adults. (2009) (83)
- Prognosis of Malignant Pheochromocytoma and Paraganglioma (MAPP-Prono Study): A European Network for the Study of Adrenal Tumors Retrospective Study. (2019) (83)
- Simultaneous liquid chromatography tandem mass spectrometric determination of urinary free metanephrines and catecholamines, with comparisons of free and deconjugated metabolites. (2013) (82)
- A Copeptin‐Based Approach in the Diagnosis of Diabetes Insipidus (2018) (81)
- DIAGNOSIS OF ENDOCRINE DISEASE: The diagnostic performance of adrenal biopsy: a systematic review and meta-analysis. (2016) (80)
- CT Characteristics of Pheochromocytoma: Relevance for the Evaluation of Adrenal Incidentaloma (2018) (80)
- Adrenocortical carcinoma -- improving patient care by establishing new structures. (2006) (80)
- Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study (2020) (79)
- Landscape of somatic mutations in sporadic GH-secreting pituitary adenomas. (2016) (78)
- High diagnostic accuracy of adrenal core biopsy: results of the German and Austrian adrenal network multicenter trial in 220 consecutive patients. (2003) (76)
- The impact of external social and internal personal forces on consumers’ brand community engagement on Facebook (2016) (75)
- Peroxisome proliferator-activated receptor-gamma agonists suppress adrenocortical tumor cell proliferation and induce differentiation. (2005) (75)
- Targeted Molecular Analysis in Adrenocortical Carcinomas: A Strategy Toward Improved Personalized Prognostication (2018) (74)
- Glucose transporter GLUT1 expression is an stage-independent predictor of clinical outcome in adrenocortical carcinoma. (2009) (74)
- [123 I]Iodometomidate for molecular imaging of adrenocortical cytochrome P450 family 11B enzymes. (2008) (74)
- Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma (2017) (72)
- Exquisite sensitivity of adrenocortical carcinomas to induction of ferroptosis (2019) (72)
- Clinical presentation, treatment and outcome of anaplastic thyroid carcinoma: results of a multicenter study in Germany. (2016) (71)
- Improved survival in patients with stage II adrenocortical carcinoma followed up prospectively by specialized centers. (2010) (70)
- Long-term Postoperative Follow-up in Patients with Apparently Benign Pheochromocytoma and Paraganglioma (2012) (68)
- Ribonucleotide Reductase Large Subunit (RRM1) Gene Expression May Predict Efficacy of Adjuvant Mitotane in Adrenocortical Cancer (2012) (66)
- Gemcitabine‐Based Chemotherapy in Adrenocortical Carcinoma: A Multicenter Study of Efficacy and Predictive Factors (2017) (65)
- PKA catalytic subunit mutations in adrenocortical Cushing’s adenoma impair association with the regulatory subunit (2014) (63)
- Expression of excision repair cross complementing group 1 and prognosis in adrenocortical carcinoma patients treated with platinum-based chemotherapy. (2009) (63)
- Comprehensive mutation scanning of NF1 in apparently sporadic cases of pheochromocytoma. (2006) (61)
- N-terminal proopiomelanocortin acts as a mitogen in adrenocortical tumor cells and decreases adrenal steroidogenesis. (2003) (61)
- No endogenous ouabain is detectable in human plasma by ultra-sensitive UPLC-MS/MS. (2014) (60)
- Single Nucleotide Polymorphism Array Profiling of Adrenocortical Tumors - Evidence for an Adenoma Carcinoma Sequence? (2013) (60)
- Phenotypic homogeneity and genotypic variability in a large series of congenital isolated ACTH-deficiency patients with TPIT gene mutations. (2012) (60)
- Thyroid function, cardiovascular events, and mortality in diabetic hemodialysis patients. (2014) (60)
- [131I]iodometomidate for targeted radionuclide therapy of advanced adrenocortical carcinoma. (2012) (59)
- Deficits in the management of patients with adrenocortical carcinoma in Germany. (2010) (58)
- Induction of CD4+ and CD8+ T-Cell Responses to the Human Stromal Antigen, Fibroblast Activation Protein: Implication for Cancer Immunotherapy (2005) (58)
- Personalized Management of Pheochromocytoma and Paraganglioma (2021) (58)
- A Copeptin-based approach in the diagnosis of diabetes insipidus (2019) (57)
- How do performance feedback characteristics influence recipients’ reactions? A state-of-the-art review on feedback source, timing, and valence effects (2018) (57)
- Prognostic impact of subclinical thyroid dysfunction in heart failure. (2013) (57)
- Release and Decay Kinetics of Copeptin vs AVP in Response to Osmotic Alterations in Healthy Volunteers (2018) (57)
- DNA Methylation Is an Independent Prognostic Marker of Survival in Adrenocortical Cancer. (2016) (56)
- Genetic Landscape of Sporadic Unilateral Adrenocortical Adenomas Without PRKACA p.Leu206Arg Mutation. (2016) (56)
- Arginine-stimulated copeptin measurements in the differential diagnosis of diabetes insipidus: a prospective diagnostic study (2019) (55)
- Erratum: Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma (Cancer Cell (2016) 29(5) (723–736) (S153561081630160X) (10.1016/j.ccell.2016.04.002)) (2016) (54)
- PheoSeq: A Targeted Next-Generation Sequencing Assay for Pheochromocytoma and Paraganglioma Diagnostics. (2017) (53)
- Side population does not define stem cell-like cancer cells in the adrenocortical carcinoma cell line NCI h295R. (2008) (51)
- Investigating the Chemokine Receptor 4 as Potential Theranostic Target in Adrenocortical Cancer Patients (2017) (51)
- Angiotensin II type 1 receptor and ACTH receptor expression in human adrenocortical neoplasms (2001) (51)
- Targeting CXCR4 (CXC Chemokine Receptor Type 4) for Molecular Imaging of Aldosterone-Producing Adenoma (2018) (50)
- Aldosterone and cortisol affect the risk of sudden cardiac death in haemodialysis patients (2012) (50)
- Comparison of two mitotane starting dose regimens in patients with advanced adrenocortical carcinoma (2013) (49)
- Retaining Customers With Shopping Convenience (2009) (49)
- Driver mutations in USP8 wild-type Cushing’s disease (2019) (49)
- New mechanisms of adrenostatic compounds in a human adrenocortical cancer cell line (2000) (47)
- Influence of Short-Term Glucocorticoid Therapy on Regulatory T Cells In Vivo (2011) (47)
- Influence of hormonal functional status on survival in adrenocortical carcinoma: systematic review and meta-analysis. (2018) (47)
- Consumer response to online/offline price differentiation (2016) (47)
- Epidermal growth factor receptor in adrenocortical tumors: analysis of gene sequence, protein expression and correlation with clinical outcome (2010) (47)
- A copeptin-based classification of the osmoregulatory defects in the syndrome of inappropriate antidiuresis. (2014) (47)
- The pro-opiomelanocortin gene of the zebrafish (Danio rerio). (2003) (46)
- Plasma steroid metabolome profiling for the diagnosis of adrenocortical carcinoma. (2019) (46)
- Role of MDH2 pathogenic variant in pheochromocytoma and paraganglioma patients (2018) (45)
- Recurrent EZH1 mutations are a second hit in autonomous thyroid adenomas. (2016) (45)
- Next-generation therapies for adrenocortical carcinoma. (2020) (44)
- Beyond Adrenal and Ovarian Androgen Generation: Increased Peripheral 5??-reductase Activity in Women With Polycystic Ovary Syndrome (2003) (44)
- Frequency and clinical correlates of somatic Ying Yang 1 mutations in sporadic insulinomas. (2015) (44)
- What is the best approach to an apparently nonmetastatic adrenocortical carcinoma? (2010) (44)
- Safety and tolerability of sorafenib in patients with radioiodine-refractory thyroid cancer (2015) (44)
- Functional characterization of adrenal lesions using [123I]IMTO-SPECT/CT. (2013) (43)
- AKT is highly phosphorylated in pheochromocytomas but not in benign adrenocortical tumors. (2005) (43)
- Measurements of plasma metanephrines by immunoassay vs liquid chromatography with tandem mass spectrometry for diagnosis of pheochromocytoma. (2015) (42)
- Value of Molecular Classification for Prognostic Assessment of Adrenocortical Carcinoma. (2019) (42)
- Interplay between glucocorticoids and tumor-infiltrating lymphocytes on the prognosis of adrenocortical carcinoma (2020) (41)
- Bariatric surgery for morbid obesity in craniopharyngioma (2013) (41)
- International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers (2021) (41)
- EJE prize 2014: current and evolving treatment options in adrenocortical carcinoma: where do we stand and where do we want to go? (2014) (41)
- Decoding the genetic basis of Cushing's disease: USP8 in the spotlight. (2015) (40)
- Clinical impact of TP53 alterations in adrenocortical carcinomas (2012) (39)
- Pheochromocytoma and paraganglioma: Clinical feature based disease probability in relation to catecholamine biochemistry and reason for disease suspicion. (2019) (39)
- CYP2W1 Is Highly Expressed in Adrenal Glands and Is Positively Associated with the Response to Mitotane in Adrenocortical Carcinoma (2014) (39)
- Computed tomography criteria for discrimination of adrenal adenomas and adrenocortical carcinomas: analysis of the German ACC registry. (2015) (38)
- EDLP versus Hi–Lo pricing strategies in retailing—a state of the art article (2013) (37)
- Steroidogenic acute regulatory protein mRNA expression in adrenal tumours. (2000) (37)
- Metastatic adrenocortical carcinoma: results of 56 pulmonary metastasectomies in 24 patients. (2011) (36)
- Single nucleotide polymorphism microarray analysis in cortisol-secreting adrenocortical adenomas identifies new candidate genes and pathways. (2012) (36)
- Luxury web atmospherics: an examination of homepage design (2013) (36)
- Comparison of two mitotane starting dose regimens in patients with advanced adrenocortical carcinoma. (2013) (35)
- Creating Online Brand Experience on Facebook (2013) (34)
- Selling luxury goods online: effects of online accessibility and price display (2015) (34)
- High-Resolution Tissue Mass Spectrometry Imaging Reveals a Refined Functional Anatomy of the Human Adult Adrenal Gland (2018) (34)
- Low SGK1 Expression in Human Adrenocortical Tumors Is Associated with ACTH-Independent Glucocorticoid Secretion and Poor Prognosis (2012) (34)
- Aminoglutethimide suppresses adrenocorticotropin receptor expression in the NCI-h295 adrenocortical tumor cell line. (1998) (34)
- Advanced Adrenocortical Carcinoma – What to do when First-Line Therapy Fails? (2018) (33)
- Assessment of serum‐free cortisol levels in patients with adrenocortical carcinoma treated with mitotane: a pilot study (2010) (33)
- Peripheral administration of the N-terminal pro-opiomelanocortin fragment 1-28 to Pomc-/- mice reduces food intake and weight but does not affect adrenal growth or corticosterone production. (2006) (32)
- Sunitinib Inhibits Cell Proliferation and Alters Steroidogenesis by Down-Regulation of HSD3B2 in Adrenocortical Carcinoma Cells (2011) (31)
- The adrenal secretory serine protease AsP is a short secretory isoform of the transmembrane airway trypsin-like protease. (2004) (31)
- Assessment of VAV2 Expression Refines Prognostic Prediction in Adrenocortical Carcinoma (2017) (31)
- Dosage-dependent regulation of VAV2 expression by steroidogenic factor-1 drives adrenocortical carcinoma cell invasion (2017) (31)
- Active steroid hormone synthesis renders adrenocortical cells highly susceptible to type II ferroptosis induction (2020) (30)
- Urine Steroid Metabolomics as a Novel Tool for Detection of Recurrent Adrenocortical Carcinoma (2019) (30)
- Opposites Attract, but Similarity Works: A Study of Interorganizational Similarity in Marketing Channels (2002) (29)
- Single-cell molecular profiling of all three components of the HPA axis reveals adrenal ABCB1 as a regulator of stress adaptation (2021) (29)
- Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer. (2017) (29)
- A phase 1 study of nevanimibe HCl, a novel adrenal-specific sterol O-acyltransferase 1 (SOAT1) inhibitor, in adrenocortical carcinoma (2020) (28)
- [¹²³I]Iodometomidate imaging in adrenocortical carcinoma. (2013) (27)
- Intraoperative haemodynamic stability in patients with phaeochromocytoma – minimally invasive vs conventional open surgery (2006) (27)
- Alterations in Protein Kinase A Substrate Specificity as a Potential Cause of Cushing Syndrome. (2019) (27)
- Cardiometabolic Disease Burden and Steroid Excretion in Benign Adrenal Tumors (2022) (26)
- The New Molecular Landscape of Cushing's Disease (2015) (26)
- Levodopa therapy in Parkinson’s disease: influence on liquid chromatographic tandem mass spectrometric-based measurements of plasma and urinary normetanephrine, metanephrine and methoxytyramine (2014) (26)
- The New Genetic Landscape of Cushing’s Disease: Deubiquitinases in the Spotlight (2019) (26)
- Notch1 pathway in adrenocortical carcinomas: correlations with clinical outcome. (2015) (26)
- Is There a Role for Laparoscopic Adrenalectomy in Patients with Suspected Adrenocortical Carcinoma? A Critical Appraisal of the Literature (2013) (26)
- Expression of LIN28 and its regulatory microRNAs in adult adrenocortical cancer (2015) (25)
- Combating the negative effects of showrooming: Successful salesperson tactics for converting showroomers into buyers (2019) (25)
- Dendritic cells as potential adjuvant for immunotherapy in adrenocortical carcinoma (2006) (25)
- Livin/BIRC7 expression as malignancy marker in adrenocortical tumors (2016) (25)
- Predictive Value of 18F-FDG PET in Patients with Advanced Medullary Thyroid Carcinoma Treated with Vandetanib (2017) (24)
- The role of regulated necrosis in endocrine diseases (2021) (24)
- Impact of USP8 Gene Mutations on Protein Deregulation in Cushing Disease. (2019) (24)
- [123I]Iodometomidate imaging in adrenocortical carcinoma (2013) (24)
- Outcome after resection of Adrenocortical Carcinoma liver metastases: a retrospective study (2017) (24)
- The Treatment of Well-Differentiated Thyroid Carcinoma. (2015) (24)
- Does bariatric surgery change olfactory perception? Results of the early postoperative course (2014) (23)
- Objective response and prolonged disease control of advanced adrenocortical carcinoma with cabozantinib. (2020) (22)
- Epidemiology of Adrenocortical Carcinoma (2009) (22)
- Impact of chronic hyponatremia on neurocognitive and neuromuscular function (2018) (21)
- Adjuvant mitotane for adrenocortical cancer--working through uncertainty. (2009) (20)
- Price Management: Strategy, Analysis, Decision, Implementation (2018) (20)
- HIF2α supports pro-metastatic behavior in pheochromocytomas/paragangliomas. (2020) (20)
- Preclinical progress and first translational steps for a liposomal chemotherapy protocol against adrenocortical carcinoma. (2016) (19)
- RNA-Sequencing and Somatic Mutation Status of Adrenocortical Tumors: Novel Pathogenetic Insights. (2020) (19)
- Impact of 123 I-MIBG scintigraphy on clinical decision making in pheochromocytoma and paraganglioma. (2019) (19)
- Extending downward is not always bad: Parent brand evaluations after brand extension to higher and lower price and quality levels (2014) (19)
- Surviving ectopic Cushing's syndrome: quality of life, cardiovascular and metabolic outcomes in comparison to Cushing's disease during long-term follow-up. (2018) (19)
- High evening salivary cortisol is an independent predictor of increased mortality risk in patients with systolic heart failure. (2016) (19)
- Differential expression of the protein kinase A subunits in normal adrenal glands and adrenocortical adenomas (2017) (19)
- Effects of Germline CYP2W1*6 and CYP2B6*6 Single Nucleotide Polymorphisms on Mitotane Treatment in Adrenocortical Carcinoma: A Multicenter ENSAT Study (2020) (19)
- Patterns of Lymph Node Recurrence in Adrenocortical Carcinoma: Possible Implications for Primary Surgical Treatment (2018) (18)
- Evidence against a role of human airway trypsin-like protease--the human analogue of the growth-promoting rat adrenal secretory protease--in adrenal tumourigenesis. (2005) (18)
- Dendritic cell based immunotherapy--a promising therapeutic approach for endocrine malignancies. (2008) (18)
- T Cell Development Critically Depends on Prethymic Stromal Patched Expression (2011) (17)
- Cortisol-related metabolic alterations assessed by mass spectrometry assay in patients with Cushing's syndrome. (2017) (17)
- Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study. (2022) (17)
- Synergistic Highly Potent Targeted Drug Combinations in different Pheochromocytoma Models including Human Tumor Cultures. (2019) (17)
- Treatment of malignant phaeochromocytoma with a combination of cyclophosphamide, vincristine and dacarbazine: own experience and overview of the contemporary literature (2015) (17)
- Plasma metanephrines and prospective prediction of tumor location, size and mutation type in patients with pheochromocytoma and paraganglioma (2020) (17)
- Association of mitotane with chylomicrons and serum lipoproteins: practical implications for treatment of adrenocortical carcinoma. (2016) (17)
- A Dangerous Liaison—Pheochromocytoma in Patients with Malignant Disease (2006) (16)
- Sino-European differences in the genetic landscape and clinical presentation of pheochromocytoma and paraganglioma. (2020) (16)
- Cancer-testis Antigen FATE1 Expression in Adrenocortical Tumors Is Associated with A Pervasive Autoimmune Response and Is A Marker of Malignancy in Adult, but Not Children, ACC (2020) (16)
- Targeted Gene Expression Profile Reveals CDK4 as Therapeutic Target for Selected Patients With Adrenocortical Carcinoma (2020) (16)
- Prognostic value of aldosterone and cortisol in patients hospitalized for acutely decompensated chronic heart failure with and without mineralocorticoid receptor antagonism. (2015) (16)
- Enzyme autoinduction by mitotane supported by population pharmacokinetic modelling in a large cohort of adrenocortical carcinoma patients. (2018) (16)
- Pregnancy in Women Previously Treated for an Adrenocortical Carcinoma. (2015) (16)
- Survivin in Adrenocortical Tumors – Pathophysiological Implications and Therapeutic Potential (2012) (16)
- Expression of SOAT1 in adrenocortical carcinoma and response to mitotane monotherapy: an ENSAT multicenter study. (2020) (16)
- Lack of utility of SDHB mutation testing in adrenergic metastatic phaeochromocytoma. (2014) (16)
- GLP-1 and PYY3-36 reduce high-fat food preference additively after Roux-en-Y gastric bypass in diet-induced obese rats. (2019) (16)
- Expression of HER-2/neu receptor protein in adrenal tumors. (2002) (15)
- Pricing Luxury Brands: Specificities, Conceptualization and Performance Impact (2013) (15)
- ERCC1 as predictive biomarker to platinum-based chemotherapy in adrenocortical carcinomas. (2018) (15)
- Imaging of C-X-C Motif Chemokine Receptor 4 Expression in 690 Patients with Solid or Hematologic Neoplasms Using 68Ga-Pentixafor PET (2022) (15)
- Osteopontin stimulates invasion of NCI‐h295 cells but is not associated with survival in adrenocortical carcinoma (2009) (14)
- Salvage Treatment of Adrenocortical Carcinoma with Trofosfamide (2016) (14)
- Inducible Knock-Down of the Mineralocorticoid Receptor in Mice Disturbs Regulation of the Renin-Angiotensin-Aldosterone System and Attenuates Heart Failure Induced by Pressure Overload (2015) (14)
- [Current TNM classification systems for adrenocortical carcinoma]. (2010) (13)
- Treatment of symptomatic hyponatremia with hypertonic saline: a real-life observational study (2021) (13)
- Targeting CXCR 4 ( CXC Chemokine Receptor Type 4 ) for Molecular Imaging of Aldosterone-Producing Adenoma (13)
- Etomidate unmasks intraadrenal regulation of steroidogenesis and proliferation in adrenal cortical cell lines. (2010) (13)
- Data set for reporting of carcinoma of the adrenal cortex: Explanations and recommendations of the guidelines from the International Collaboration on Cancer Reporting (ICCR). (2020) (13)
- Metabolic impact of pheochromocytoma/paraganglioma: Targeted metabolomics in patients before and after tumor removal. (2019) (13)
- Prognostic Relevance of Steroid Sulfation in Adrenocortical Carcinoma Revealed by Molecular Phenotyping Using High-Resolution Mass Spectrometry Imaging. (2019) (13)
- Adrenomedullary function, obesity and permissive influences of catecholamines on body mass in patients with chromaffin cell tumours (2019) (12)
- Radiation Exposure of Adrenal Vein Sampling - a German Multicenter Study. (2018) (12)
- Adjuvant radiation therapy of the tumor bed prevents local recurrences in adrenocortical carcinoma (2006) (12)
- [Adrenocortical carcinoma. Diagnostic work-up and treatment]. (2008) (12)
- Treatment of Refractory Adrenocortical Carcinoma with Thalidomide: Analysis of 27 Patients from the European Network for the Study of Adrenal Tumours Registry. (2018) (12)
- Glucocorticoid Excess in Patients with Pheochromocytoma Compared with Paraganglioma and Other Forms of Hypertension (2020) (12)
- Management of Patients With Glucocorticoid-Related Diseases and COVID-19 (2021) (12)
- Impact of the Chemokine Receptors CXCR4 and CXCR7 on Clinical Outcome in Adrenocortical Carcinoma (2020) (12)
- Heat Shock Protein 90 as a Prognostic Marker and Therapeutic Target for Adrenocortical Carcinoma (2019) (12)
- Genetic testing in inherited endocrine disorders: joint position paper of the European reference network on rare endocrine conditions (Endo-ERN) (2020) (12)
- [German adrenocortical carcinoma registry. Surgical therapy results and follow-up treatment]. (2012) (11)
- FGF-Receptors and PD-L1 in Anaplastic and Poorly Differentiated Thyroid Cancer: Evaluation of the Preclinical Rationale (2021) (11)
- Prognostic value of histological markers in localized adrenocortical carcinoma after complete resection (2013) (11)
- Early Postoperative Circulating miR-483-5p Is a Prognosis Marker for Adrenocortical Cancer (2020) (11)
- Drug Synergism of Proteasome Inhibitors and Mitotane by Complementary Activation of ER Stress in Adrenocortical Carcinoma Cells (2016) (11)
- S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study (2021) (11)
- A method for the minimally invasive drug monitoring of mitotane by means of volumetric absorptive microsampling for a home-based therapeutic drug monitoring (2019) (11)
- What Is the Optimal Duration of Adjuvant Mitotane Therapy in Adrenocortical Carcinoma? An Unanswered Question (2021) (10)
- Method-Specific Cortisol and Dexamethasone Thresholds Increase Clinical Specificity of the Dexamethasone Suppression Test for Cushing Syndrome. (2021) (10)
- Analysis of Telomere Maintenance Related Genes Reveals NOP10 as a New Metastatic-Risk Marker in Pheochromocytoma/Paraganglioma (2021) (10)
- CXCR4-targeted theranostics in oncology (2022) (10)
- Clodronate inhibits adrenocortical cell proliferation and P450c21 activity. (2002) (10)
- Calcium stimulated calcitonin measurement: a procedural proposal. (2013) (10)
- A Novel Patient-Derived Cell Line of Adrenocortical Carcinoma Shows a Pathogenic Role of Germline MUTYH Mutation and High Tumour Mutational Burden (2020) (10)
- Clinical Spectrum of Primary Adrenal Lymphoma: Results of a Multicenter Cohort Study. (2020) (9)
- 567O First International Randomized Study in Malignant Progressive Pheochromocytoma and Paragangliomas (FIRSTMAPPP): An academic double-blind trial investigating sunitinib (2021) (9)
- Results of the ADIUVO Study, the First Randomized Trial on Adjuvant Mitotane in Adrenocortical Carcinoma Patients (2021) (9)
- Real world efficacy and safety of multi-tyrosine kinase inhibitors in radioiodine refractory thyroid cancer. (2021) (9)
- Assessment of tumor heterogeneity in treatment-naïve adrenocortical cancer patients using 18F-FDG positron emission tomography (2016) (9)
- Silencing of the mineralocorticoid receptor by ribonucleic acid interference in transgenic rats disrupts endocrine homeostasis. (2008) (9)
- Volumetric and texture analysis of pretherapeutic 18F-FDG PET can predict overall survival in medullary thyroid cancer patients treated with Vandetanib (2018) (9)
- Expression of 11beta-hydroxysteroid-dehydrogenase type 2 in human thymus (2016) (9)
- ENSAT Registry-Based Randomized Clinical Trials for Adrenocortical Carcinoma. (2020) (9)
- Adrenocortical incidentalomas and bone: from molecular insights to clinical perspectives (2018) (9)
- Missed clinical clues in patients with pheochromocytoma/paraganglioma discovered by imaging (2018) (9)
- Circulating microRNA Expression in Cushing’s Syndrome (2021) (9)
- High expression of Sterol-O-Acyl transferase 1 (SOAT1), an enzyme involved in cholesterol metabolism, is associated with earlier biochemical recurrence in high risk prostate cancer (2021) (8)
- Less common genotype variants of TP53 polymorphisms are associated with poor outcome in adult patients with adrenocortical carcinoma. (2014) (8)
- Steroid Profiling for Adrenocortical Disorders: A Pathway for Omics-Based Diagnostics. (2017) (8)
- Oral glucose tolerance testing but not intravenous glucose administration uncovers hyper‐responsiveness of hypothalamo–pituitary–adrenal axis in patients with adrenal incidentalomas (2000) (8)
- Harmonization of LC-MS/MS Measurements of Plasma Free Normetanephrine, Metanephrine, and 3-Methoxytyramine. (2021) (8)
- Toward a Medical Gastric Bypass: Chronic Feeding Studies With Liraglutide + PYY3-36 Combination Therapy in Diet-Induced Obese Rats (2021) (8)
- Adjuvant platinum-based chemotherapy in radically resected adrenocortical carcinoma: a cohort study (2021) (8)
- Lack of Ubiquitin Specific Protease 8 (USP8) Mutations in Canine Corticotroph Pituitary Adenomas (2016) (8)
- The Adrenal Gland: Central Relay in Health and Disease (2019) (7)
- Adrenocortical Carcinoma in Childhood: A Systematic Review (2021) (7)
- Bone metastases in medullary thyroid carcinoma: high morbidity and poor prognosis associated with osteolytic morphology. (2020) (7)
- Adrenal wash-out CT: moderate diagnostic value in distinguishing benign from malignant adrenal masses (2021) (7)
- Role of Endocrine Gland-Derived Vascular Endothelial Growth Factor (EG-VEGF) and Its Receptors in Adrenocortical Tumors (2015) (7)
- Radiation exposure of adrenal vein sampling: a German Multicenter Study (2018) (7)
- Case Report: Abdominal Lymph Node Metastases of Parathyroid Carcinoma: Diagnostic Workup, Molecular Diagnosis, and Clinical Management (2021) (6)
- Plasma steroid profiling in patients with adrenal incidentaloma. (2021) (6)
- Inhibition of Cholesterol Esterification in the Adrenal Gland by ATR101/PD132301-2, A Promising Case of Drug Repurposing. (2016) (6)
- Do Luxury Pricing Decisions Create Price Continuity (2012) (6)
- Identification of predictive criteria for pathogenic variants of the Primary Bilateral Macronodular Adrenal Hyperplasia gene ARMC5 in 352 unselected patients. (2022) (6)
- A Neonatal Form of Isolated ACTH Deficiency Frequently Associated with Tpit Gene Mutations (2004) (6)
- Hsp90 inhibition in adrenocortical carcinoma: Limited drug synergism with mitotane (2019) (6)
- Determinants of choice satisfaction in a high-involvement product choice (2015) (6)
- Epithelial and Mesenchymal Markers in Adrenocortical Tissues: How Mesenchymal Are Adrenocortical Tissues? (2021) (6)
- Impact of Tumor Burden on Normal Organ Distribution in Patients Imaged with CXCR4-Targeted [68Ga]Ga-PentixaFor PET/CT (2022) (6)
- Intratumor heterogeneity of prognostic DNA-based molecular markers in adrenocortical carcinoma (2020) (6)
- The Veblen effect and (in)conspicuous consumption - a state of the art article (2018) (6)
- The natural history of adrenal incidentaloma - results from the international prospective multi-centre EURINE-ACT study (2017) (6)
- ATR-101 phase 1 clinical study for adrenocortical carcinoma. (2015) (6)
- First German Guideline on Diagnostics and Therapy of Clinically Non-Functioning Pituitary Tumors. (2021) (5)
- Safety and tolerability of sorafenib for treatment of locally advanced or metastatic radioactive iodine-refractory differentiated thyroid cancer (RAI-rDTC): Detailed analyses from the phase III DECISION trial. (2014) (5)
- Identifying New Potential Biomarkers in Adrenocortical Tumors Based on mRNA Expression Data Using Machine Learning (2021) (5)
- Our experience with the management of patients with non-metastatic adrenocortical carcinoma. (2022) (5)
- Dyslipidemia causes overestimation of plasma mitotane measurements (2016) (5)
- Confirmatory testing of primary aldosteronism with saline infusion test and LC-MS/MS (2020) (5)
- Low SGK 1 Expression in Human Adrenocortical Tumors Is Associated with ACTH-Independent Glucocorticoid Secretion and Poor Prognosis (2012) (5)
- The challenges of sodium measurements - indirect versus direct ion selective method. (2019) (5)
- Deutsches Nebennierenrindenkarzinom-Register (2012) (5)
- Biochemical diagnosis of pheochromocytoma using plasma free normetanephrine, metanephrine and methoxytyramine: importance of supine sampling under fasting conditions (2013) (5)
- Multicenter case series of primary adrenal lymphoma (2016) (4)
- A novel patient-derived cell line of adrenocortical carcinoma shows a pathogenic role of germline MUTYH mutation and high tumour mutational burden. (2021) (4)
- Roux-en-Y Gastric Bypass and Caloric Restriction but Not Gut Hormone-Based Treatments Profoundly Impact the Hypothalamic Transcriptome in Obese Rats (2021) (4)
- Defensive Relationship Marketing: Avoiding Decreasing Sales From Customers in Consumer Goods Mass Markets (2008) (4)
- Long-term effects of radiotherapy on cardiovascular risk factors in acromegaly. (2011) (4)
- Hypertension and hypertensive cardiomyopathy in patients with a relapse‐free history of phaeochromocytoma (2015) (4)
- Etoposide, doxorubicin, cisplatin, and mitotane versus streptozotocin and mitotane in adrenocortical carcinoma: preliminary results from the first international phase III trial: the FIRM-ACT study (2011) (4)
- International randomized, double-blind, placebo-controlled, phase 3 study of linsitinib (OSI-906, L) in patients (pts) with locally advanced or metastatic adrenocortical carcinoma (ACC). (2014) (4)
- Testing the influence of real-time performance feedback on employees in digital services (2020) (4)
- Excerpt from ‘ Price Management – Strategy , Analysis , Decision , Implementation ’ (2019) (4)
- Impact of surgery on clinical outcome in patients with recurrence of adrenocortical carcinoma (2009) (4)
- [Pheochromocytoma - Current Recommendations on Diagnostics, Therapy and Follow-up]. (2017) (4)
- Influence of short-term glucocorticoid therapy on regulatory T cells (2010) (4)
- First randomized trial on adjuvant mitotane in adrenocortical carcinoma patients: The Adjuvo study. (2022) (4)
- [Obesity and heart failure]. (2015) (4)
- The role of molecular profiling in adrenocortical carcinoma (2021) (4)
- Reply to Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma (2009) (3)
- Plasma Metabolome Profiling for the Diagnosis of Catecholamine Producing Tumors (2021) (3)
- Sunitinib in refractory adrenocortical carcinoma: results of a phase II trial (2011) (3)
- A case report of a solitary pancreatic metastasis of an adrenocortical carcinoma (2015) (3)
- Luxury–Specific Dimensions of Customer–Salesperson Relationships (2017) (3)
- [New therapeutic options for advanced thyroid cancer]. (2011) (3)
- Targeted metabolic profiling of urinary steroids with a focus on analytical accuracy and sample stability (2022) (3)
- [Surgery as pluripotent instrument for metabolic disease. What are the mechanisms?]. (2014) (3)
- The Diagnosis and Management of Endocrine Side Effects of Immune Checkpoint Inhibitors. (2021) (3)
- Visualization of Tumor Heterogeneity in Advanced Medullary Thyroid Carcinoma by Dual-Tracer Molecular Imaging: Revealing the Theranostic Potential of SSTR- and PSMA-Directed Endoradiotherapy. (2022) (3)
- Prognostic factors of advanced unresectable by stage III and IV ENS@T adrenocortical carcinomas (ACC) (2013) (3)
- Epidermal growth factor receptor (EGFR) as a potential new target in the treatment of patients with adrenocortical carcinoma – results of pre-clinical studies (2007) (3)
- Metyrapone Versus Osilodrostat in the Short-Term Therapy of Endogenous Cushing’s Syndrome: Results From a Single Center Cohort Study (2022) (3)
- Mass Spectrometry Imaging Identifies Metabolic Patterns Associated with Malignant Potential in Pheochromocytoma and Paraganglioma. (2021) (3)
- Do mitotane levels impact on the outcome of patients treated adjuvantly following radical resection of adrenocortical cancer (ACC) (2011) (3)
- Sales Promotion Management in Retailing: Tasks, Benchmarks, and Future Trends (2015) (3)
- Targeted molecular analysis in adrenocortical carcinomas: a strategy towards improved personalized prognostication (2018) (3)
- Novel CYP11B-ligand [123/131I]IMAZA as promising theranostic tool for adrenocortical tumors: comprehensive preclinical characterization and first clinical experience (2021) (3)
- FGF/FGFR signaling in adrenocortical development and tumorigenesis: novel potential therapeutic targets in adrenocortical carcinoma (2022) (3)
- Systemic treatment of advanced differentiated and medullary thyroid cancer (2015) (3)
- Personalized drug testing in human pheochromocytoma/paraganglioma primary cultures. (2022) (3)
- [Arterial hypertension and subclinical Cushing's syndrome]. (2010) (3)
- Case Report: Consecutive Adrenal Cushing’s Syndrome and Cushing’s Disease in a Patient With Somatic CTNNB1, USP8, and NR3C1 Mutations (2021) (3)
- [Pheochromocytoma: current diagnostics and treatment]. (2010) (3)
- Impact of Lymphadenectomy on the Oncologic Outcome of Patients with Adrenocortical Carcinoma—A Systematic Review and Meta-Analysis (2022) (3)
- Adrenal crisis and general morbidity in chronic adrenal insufficiency prospectively assessed in 472 patients (2011) (3)
- Reassessment of postural stimulation testing as a simple tool to identify a subgroup of patients with unilateral primary aldosteronism. (2021) (3)
- Preanalytical considerations and out-patient vs in-patient tests of plasma metanephrines to diagnose pheochromocytoma. (2022) (2)
- PKA Cα subunit mutation triggers caspase-dependent RIIβ subunit degradation via Ser114 phosphorylation (2021) (2)
- [Obesity and heart failure]. (2008) (2)
- Targeting 11-beta hydroxylase with [ 131I]IMAZA - a novel approach for the treatment of advanced adrenocortical carcinoma. (2021) (2)
- Definition and diagnosis of postsurgical hypoparathyroidism after thyroid surgery: meta-analysis (2022) (2)
- Cardio-psycho-metabolic outcomes of bariatric surgery: design and baseline of the WAS trial (2022) (2)
- Variations in cardiovascular risk factors in people with and without migration background in Germany - Results from the STAAB cohort study. (2019) (2)
- Adrenal Cancer: Scientific Advances (2012) (2)
- Adrenal Functional Imaging. (2022) (2)
- The zebrafish as a model organism to study adrenal development (2004) (2)
- Measurements of plasma metanephrines by immunoassay versus LC-MS/MS for diagnosis of pheochromocytoma (2014) (2)
- Oxytocin Levels in Response to Pituitary Provocation Tests in Healthy Volunteers (2021) (2)
- 131I-Iodometomidate radiotherapy for metastatic adrenocortical carcinoma: first clinical experience (2009) (2)
- The IGF2 methylation score for adrenocortical cancer: an ENSAT validation study. (2020) (2)
- [123/131I](R)-1-[1-(4-iodophenyl)ethyl]-1H-imidazole-5-carboxylic acid azetidinylamide (IMAZA) – A novel radiotracer for diagnosis and treatment of adrenocortical tumours – From bench to bedside (2015) (2)
- Faculty Opinions recommendation of Treatment with sunitinib for patients with progressive metastatic pheochromocytomas and sympathetic paragangliomas. (2012) (2)
- CT criteria for adrenal cancer - analysis of the German ACC registry (2013) (2)
- Pre- versus post-operative untargeted plasma nuclear magnetic resonance spectroscopy metabolomics of pheochromocytoma and paraganglioma (2021) (2)
- Modified GRAS Score for Prognostic Classification of Adrenocortical Carcinoma: An ENSAT Multicentre Study (2020) (2)
- Brand Name Strategies for Successful Upward Extension (2015) (2)
- Mitotane induces endoplasmic reticulum stress triggering apoptosis and decrease of steroid hormone synthesis (2014) (2)
- A novel theranostic concept for Adrenocortical Neoplasia targeting the chemokine receptor CXCR4 (2015) (2)
- [Adrenocortical carcinoma and pregnancy]. (2016) (2)
- Adrenocortical carcinoma: current and future therapeutic options (2007) (2)
- Mitotane inhibits sterol-o-acyltransferase leading to lipid-mediated endoplasmic reticulum stress and apoptosis of adrenocortical carcinoma cells (2015) (2)
- The Interdisciplinary Management of Newly Diagnosed Pituitary Tumors. (2021) (2)
- Urine steroid metabolomics is a highly sensitive tool for post-operative recurrence detection in adrenocortical carcinoma (2016) (2)
- Reduction of Radiation Exposure in Adrenal Vein Sampling: Impact of the Rapid Cortisol Assay (2021) (2)
- Diagnosis and management of hypertension in patients with Cushing's syndrome: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension (2022) (2)
- Reply to letter: "regional lymphadenectomy for adrenocortical carcinoma". (2013) (2)
- Liraglutide + PYY3-36 Combination Therapy Mimics Effects of Roux-en-Y Bypass on Early NAFLD Whilst Lacking-Behind in Metabolic Improvements (2022) (2)
- Successful treatment of two patients with refractory hypoparathyroidism by continuous subcutaneous administration of recombinant PTH (1 – 34) (2015) (2)
- Constitutive activation of PRKACA in adrenal Cushing's syndrome (2014) (2)
- Results of the ADIUVO trial, the first randomized study on post-operative adjuvant mitotane in patients with adrenocortical carcinoma (2021) (2)
- Incidence of hyperkalemia during hypertonic saline test for the diagnosis of diabetes insipidus (2021) (2)
- [Adrenal incidentaloma - what to do and what not?] (2017) (2)
- Price Management for Services (2018) (1)
- Decision: Long-Term Price Optimization (2018) (1)
- Decision: One-Dimensional Prices (2018) (1)
- Chemokine receptor expression in the adrenal cortex and in adrenocortical tumours (2007) (1)
- Predicitve Value of FDG Uptake in the Remaining Adrenal Gland Following Adrenalectomy for Adrenocortical Cancer (2020) (1)
- Online grocery shopping: Determinants of online impulse buying behavior (2011) (1)
- Price Management for Consumer Goods (2018) (1)
- [Thyroid gland and the heart : Pathophysiological background, diagnostic and therapeutic consequences]. (2018) (1)
- Price Strategy (2018) (1)
- Chemokine receptor 7 is highly expressed in the adrenal cortex and in benign and malignant adrenocortical tumours but does not show prognostic relevance in adrenal cancer (2015) (1)
- Somatostatin receptor-directed molecular imaging for therapeutic decision-making in patients with medullary thyroid carcinoma (2022) (1)
- TP53 and adrenocortical cancer: analysis of germline mutations and polymorphic changes in 140 patients (2011) (1)
- Preanalytical Pitfalls in Untargeted Plasma Nuclear Magnetic Resonance Metabolomics of Endocrine Hypertension (2022) (1)
- Expression of CYP2W1 in the adrenal gland: relationship with hormone secretion and clinical outcome (2014) (1)
- Prevention of hypertensive crises in rats induced by acute and chronic norepinephrine excess. (2010) (1)
- Successful combination of selpercatinib and radioiodine after pretherapeutic dose estimation in RET-altered thyroid carcinoma (2022) (1)
- 2MO EO2401 (EO) therapeutic vaccine for patients (pts) with adrenocortical carcinoma (ACC) and malignant pheochromocytoma/paraganglioma (MPP): Phase I/II SPENCER study (2022) (1)
- [Hormone therapy through changing times]. (2016) (1)
- Prognostic Role of Targeted Methylation Analysis in Paraffin-embedded Samples of Adrenocortical Carcinoma (2022) (1)
- Expression of the Chemokine Receptor CCR7 in the Normal Adrenal Gland and Adrenal Tumors and Its Correlation with Clinical Outcome in Adrenocortical Carcinoma (2021) (1)
- The metabolic phenotype of patients with primary aldosteronism: impact of subtype and sex - a multicenter-study of 3566 Caucasian and Asian subjects. (2022) (1)
- Analysis: The Psychology of Price (2018) (1)
- Prognostic value of DNA methylation in adrenocortical carcinomas: an ENSAT study (2014) (1)
- 1919P Nintedanib (BIBF1120) after first line therapy in progressive medullary thyroid cancer: A multicenter EORTC prospective randomized double-blind phase II study (NCT01788982) (2020) (1)
- [ 123/131 I] azetidinylamide a novel radiotracer for diagnosis and treatment of adrenocortical tumours -- from bench to bedside (2015) (1)
- Subtype-specific pattern of white blood cell differential in endogenous hypercortisolism. (2022) (1)
- Peroxisome proliferator activated receptor gamma (PPARγ) agonists suppress adrenocortical tumor cell proliferation and induce differentiation (2005) (1)
- [Effects of drugs on the adrenal cortex and its tumors]. (2006) (1)
- Adrenal Cancer: Clinical Advances (2011) (1)
- Mild autonomous cortisol excess in adrenal incidentalomas - metabolic disease burden and urinary steroid metabolome in 1201 prospectively recruited patients (2017) (1)
- Consecutive adrenal cushing´s syndrome and cushing´s disease in a patient with somatic CTNNB1, USP8, and NR3c1 mutations (2021) (1)
- [Severe Vitamin D(dihydrotachysterol)-intoxication with temporary anemia and hypercalcemia responsive to bisphosphonates] (2001) (1)
- Clinical presentation, treatment and outcome of anaplastic thyroid carcinoma in Germany: a retrospective multi-center study (2016) (1)
- Hypothalamic integrity is necessary for sustained weight loss after bariatric surgery: A prospective, cross-sectional study. (2022) (1)
- Prognostic role of targeted methylation analysis in formalin-fixed paraffin-embedded samples of adrenocortical carcinoma (2022) (1)
- Improved Diagnostic Accuracy of Clonidine Suppression Testing Using an Age-Related Cutoff for Plasma Normetanephrine (2022) (1)
- Epidermal growth factor receptor (EGFR) as a potential new target in the treatment of patients with adrenocortical carcinoma: Results of pre-clinical studies (2007) (1)
- New cancer drug targets identified in adrenocortical carcinoma through gene expression profiling (2018) (1)
- Prognostic factors of overall survival of stage III or IV adrenocortical carcinomas (ACC): A multicenter ENS@T study. (2014) (1)
- Outcome of CRH stimulation test and overnight 8 mg dexamethasone suppression test in 469 patients with ACTH-dependent Cushing’s syndrome (2022) (1)
- Radiotherapy for pediatric adrenocortical carcinoma – Review of the literature (2022) (1)
- Assessment of prognostic factors in pediatric adrenocortical tumors: A systematic review and evaluation of a modified S-GRAS-Score. (2022) (1)
- Impaired quality of life in patients with adrenal insufficiency evidence that improved glucocorticoid replacement strategies are needed (2006) (1)
- Targeted molecular analysis in adrenocortical carcinomas: a way towards improved personalized prognostication (2018) (1)
- Urinary Steroid Profiling as a High-Throughput Screening Tool for the Detection of Malignancy in Patients with Adrenal Tumors (2010) (1)
- [Adrenal incidentaloma - differential diagnosis and management]. (2022) (1)
- [ 123 I]Iodometomidate as a radiotracer for adrenal scintigraphy first clinical experience (2007) (1)
- Role of FGF Receptors and Their Pathways in Adrenocortical Tumors and Possible Therapeutic Implications (2021) (1)
- Clinical Presentation and Initial Diagnosis (2009) (1)
- Abstract 2976: Comprehensive Pan-Genomic characterization of adrenocortical carcinoma (2015) (1)
- CROSS-CHANNEL PRICING: WHAT WE KNOW AND WHAT WE NEED TO KNOW (2015) (1)
- Impact of preoperative weight loss achieved by gastric balloon on peri- and postoperative outcomes of bariatric surgery in super-obese patients: a retrospective matched-pair analysis (2022) (1)
- Mesenchymal tissue markers as potential drug targets in adrenocortical tumours (2018) (0)
- Value Creation within a Service Dominant Logic for Marketing (2015) (0)
- The Notch ligand Jagged1 is up-regulated in adrenocortical carcinomas and is associated with a favourable clinical outcome (2015) (0)
- Simulation-based interpretation of therapeutically monitored cabozantinib plasma concentration in advanced adrenocortical carcinoma with hemodialysis. (2021) (0)
- Outcome after resection of Adrenocortical Carcinoma liver metastases: a retrospective study (2017) (0)
- Demographics of adrenal incidentaloma - results from an international prospective multi-centre study in 2190 patients (2016) (0)
- Persistent Hypertension after successful resection of pheochromocytomas – results of a retrospective follow-up study (2013) (0)
- A metastatic ACC mouse model: Combined inactivation of Znrf3 & Tp53 results in consistent adrenocortical carcinoma formation (2022) (0)
- [123I]Iodometomidate as a radiotracer for adrenal scintigraphy – first in vivo experience (2007) (0)
- [Not Available]. (2010) (0)
- Efficacy and safety of radiation therapy in advanced adrenocortical carcinoma (2022) (0)
- Cell Atlas at Single-Nuclei Resolution of the Adult Human Adrenal Gland and Adrenocortical Adenomas (2022) (0)
- The effect of a TRB-3 knockdown on cholesterol absorption in THP-1 cells and macrophages (2013) (0)
- Germline CYP2W1*6 and CYP2B6*6 polymorphisms as predicting markers of sensitivity to mitotane treatment in advanced adrenocortical carcinoma: a multicentric ENSAT study (2018) (0)
- Imaging adrenal lesions with I-123-Iodometomidate: Semiquantitative and qualitative assessment (2012) (0)
- Changes in Plasma Metabolomic Profile Following Bariatric Surgery, Lifestyle Intervention or Diet Restriction—Insights from Human and Rat Studies (2023) (0)
- Steroid hormones and cancer immunity - insights into adrenocortical carcinoma (2019) (0)
- Evaluation of the Molecular Pathogenesis of Adrenocortical Tumors by Whole-Genome Sequencing (2021) (0)
- P3561Detection and functional characterization of angiotensin receptor type 1 autoantibodies: establishment and clinical translation (2019) (0)
- The LaHeF1-Y1 mouse as a model organism for in vivo evaluation of 123I-iodometomidate as radiotracer for adrenal imaging (2006) (0)
- SAT-354 Characterization of Cell Death Induced by SOAT1 Inhibition in Adrenocortical Carcinoma Cells (2019) (0)
- [A 47-year-old patient with paroxysmal arterial hypertension and gastric tumors]. (2012) (0)
- Differential expression of the PKA subunits in adrenocortical adenomas (2015) (0)
- [Malignant tumors of the adrenal cortex]. (2002) (0)
- 131I-Iodometomidate radiotherapy for metastatic adrenocortical carcinoma - A new treatment option? (2008) (0)
- Abstract LB-182: Constitutive activation of PRKACA in adrenal Cushing's syndrome (2014) (0)
- The role of cytotoxic chemotherapy in adjuvant treatment of radically resected adrenocortical carcinoma (2020) (0)
- The New Molecular Landscape of Cushing's (2015) (0)
- Cellular landscape of adrenocortical carcinomas determined by molecular profiling of primary, recurrent and metastatic tumour samples at single-nuclei resolution. (2023) (0)
- Machine Learning Based Algorithm as an Innovative Approach for the Differentiation Between Diabetes Insipidus and Primary Polydipsia in Clinical Practice. (2022) (0)
- A new LC-MS/MS method for simultaneous determination of six steroids in urine for the diagnostic workup of primary aldosteronism (2023) (0)
- Differential expression of protein kinase A catalytic and regulatory subunits in adrenocortical adenomas (2016) (0)
- Muscle strength in Cushing's syndrome: cross-sectional evaluation of the German Cushing's registry (2016) (0)
- Towards a registry for rare malignant tumors of the thyroid (2014) (0)
- Cardiometabolic disease burden and urine steroid metabolome in benign adrenocortical tumours: a case-control study (2021) (0)
- Recurrent somatic mutations in Ying Yang 1 (YY1) are found in a subgroup of sporadic insulinomas (2015) (0)
- [123I]Iodometomidate imaging in adrenocortical carcinoma: Evaluation of 58 patients (2013) (0)
- Potent adrenostatic activity of etomidate derivatives developed for adrenal imaging (2005) (0)
- Subtype-specific pattern of white blood cell differential in endogenous Cushing's syndrome (2022) (0)
- Phenoxybenzamine, urapidil and nitrendipine for prevention of hypertensive crisis in a rat model for acute and chronic norepinephrine excess (2007) (0)
- Faculty Opinions recommendation of Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension. (2013) (0)
- Copy number alterations and loss of heterozygosity in cortisol-secreting adrenocortical adenomas using SNP arrays: evidence of new candidate genes and pathways. (2012) (0)
- The notch ligand Jagged1 is up-regulated in adrenocortical carcinomas and might induce NOTCH1 signaling pathway activation (2015) (0)
- Endocrine gland-derived vascular endothelial growth factor and its receptors in adrenocortical carcinoma (2009) (0)
- The German Adrenocortical Carcinoma (ACC) Registry – establishment and first results (2004) (0)
- University of Birmingham Constitutive activation of PKA catalytic subunit in Adrenal Cushing's Syndrome (2014) (0)
- Circulating cell-free DNA for prognostication and disease surveillance in adrenocortical carcinoma (2021) (0)
- Protocol for the multimodal treatment of undifferentiated (anaplastic) thyroid carcinoma (2015) (0)
- Recent advances in the diagnosis and treatment of adrenocortical carcinoma (2010) (0)
- Correction: Steroidogenesis in the NCI-H295 Cell Line Model is Strongly Affected By Culture Conditions and Substrain. (2020) (0)
- Urinary steroid profiling demonstrates induction of CYP3A4 and inhibition of 5alpha-reductase by mitotane treatment for adrenocortical carcinoma (2012) (0)
- Eighteenth Conference on the Adrenal Cortex Munich, Germany June 25–27, 2018 (2019) (0)
- Delta-like non-canonical Notch ligand 1 (DLK1) - a novel biomarker in adrenocortical carcinoma (2022) (0)
- Cyclin dependent kinase 4 as promising drug target in adrenocortical carcinoma (2019) (0)
- Role of MDH2 pathogenic variant in pheochromocytoma and paraganglioma patients (2018) (0)
- Prognostic and predictive role of topoisomerase alpha 2 and thymidylate synthase expression in tumor tissues of patients with adrenocortical carcinoma (2017) (0)
- Women with preeclampsia show altered cortico- and sex steroid profiles (2023) (0)
- Prolonged exposure to target mitotane concentrations is associated with better recurrence-free survival in patients with adrenocortical carcinoma on adjuvant treatment (2023) (0)
- Price Management for Industrial Goods (2018) (0)
- Single-nuclei transcriptome of adult human adrenal glands reveals novel insights into molecular mechanisms intrinsic to adrenocortical tumourigenesis and cortisol secretion (2022) (0)
- Evidence for intraadrenal feed back regulation of steroidogenesis (2004) (0)
- SUN-348 Cabozantinib in Advanced Adrenocortical Carcinoma: Rationale and Protocol of Two Phase II Clinical Trials (2019) (0)
- Mitotane induces a concentration-dependent impairment of platelet aggregation in patients with adrenocortical carcinoma (2008) (0)
- 123I-Iodometomidate as a radiotracer for the evaluation of adrenal tumours and adrenocortical carcinoma (2008) (0)
- Plasma Concentration of o,p'DDD (Mitotane), o,p'DDA and o,p'DDE as Predictors of Tumor Response in Adrenocortical Carcinoma : Results of a Retrospective European Network for the Study of Adrenal Tumors (ENS@T) Multicentre Study. (2010) (0)
- Prospective prediction of germ line mutations in patients with pheochromocytomas and paragangliomas according to biochemical profiles (2015) (0)
- OR12-3 Identification of Predictive Criteria for the Primary Bilateral Macronodular Adrenal Hyperplasia Gene ARMC5: A European Series of 352 Unselected Patients. (2022) (0)
- Faculty Opinions recommendation of Transcriptome analysis reveals that p53 and {beta}-catenin alterations occur in a group of aggressive adrenocortical cancers. (2011) (0)
- Inhibition of IGF-II signal transduction improves chemosensitivity in human adrenocortical cancer cells (2006) (0)
- Glucocorticoid withdrawal and glucocorticoid-induced adrenal insufficiency: Study protocol of the randomized controlled «TOASST” (Taper Or Abrupt Steroid STop) multicenter trial (2023) (0)
- Prethymic Stromal Patched Expression T Cell Development Critically Depends on (2011) (0)
- Decision: Multidimensional Prices (2018) (0)
- Urinary steroid profiling as a biomarker tool for the detection of adrenal malignancy: results of the EURINE ACC Study (2009) (0)
- Adverse events of mitotane treatment in patients with adrenocortical carcinoma (2021) (0)
- [Recent advances in adrenal diseases]. (2011) (0)
- Molecular classifiers refine the prognostic stratification of adrenocortical carcinoma (2018) (0)
- The promising role of Agouti related peptide in the differentiation of ACTH-independent Cushing syndrome (0)
- Targeting immune evasion in cancer immunotherapy. (2006) (0)
- In silico neoantigen prediction - a forceful avenue to improve immunotherapy in human adrenocortical carcinoma (2023) (0)
- CAR-T cell therapy exerts effective antitumor efficacy under immunosuppressive conditions in adrenocortical carcinoma (2023) (0)
- Expression of inhibitor of apoptosis protein BIRC7/livin in adrenocortical tumors (2014) (0)
- Chemotherapy and radiotherapy for adrenocortical carcinoma (ACC) (2009) (0)
- Simplified urinary steroid profiling by LC-MS as diagnostic tool for malignancy in adrenocortical tumors. (2023) (0)
- Characterization of cell death induced by mitotane in adrenocortical carcinoma cells (2019) (0)
- Plasma Concentrations of o,p (cid:1) DDD, o,p (cid:1) DDA, and o,p (cid:1) DDE as Predictors of Tumor Response to Mitotane in Adrenocortical Carcinoma: Results of a Retrospective ENS@T Multicenter Study (2011) (0)
- WEE1 kinase inhibitor, adavosertib (AZD1775), as a novel potential therapeutic strategy in advanced adrenocortical carcinoma (2023) (0)
- In Situ Metabolomics of Cortisol-Producing Adenomas. (2022) (0)
- Diabetes, Hypertension and Obesity - not Everything is Metabolic Syndrome (2007) (0)
- M36 – Clinical Management of Adrenocortical Carcinoma (2012) (0)
- SUN-350 Sterol-O-Acyl Transferase 1 Protein Expression Alone Is Not Sufficient to Predict Response to Mitotane Treatment in Adrenocortical Carcinoma (2019) (0)
- High JAG1 expression in adrenocortical carcinomas is associated with better prognosis (2014) (0)
- methoxytyramine spectrometric-based measurements of plasma and urinary normetanephrine, metanephrine and Levodopa therapy in Parkinson's disease: influence on liquid chromatographic tandem mass (2013) (0)
- Recovery of adrenal function after stopping mitotane in patients with adrenocortical carcinoma (2023) (0)
- Liraglutide and PYY3–36 combination therapy partially achieves the metabolic benefits of Roux-en-Y gastric bypass surgery in diet-induced obese rats (2020) (0)
- Response Letter to the Editor from Sweeney AT: "CT Characteristics of Pheochromocytoma: Relevance for the Evaluation of Adrenal Incidentaloma". (2020) (0)
- [Update on treatment resistant hypertension and secondary hypertension]. (2021) (0)
- FGF-21 levels in polyuria-polydipsia syndrome (2018) (0)
- Price Management and Institutional Context (2018) (0)
- 6 Limited effects of bariatric surgery in patients with craniopharyngioma – bariatric surgery as a “neurosurgical” intervention? (2021) (0)
- P5450Evening levels and circadian changes of salivary cortisol predict adverse events in heart failure patients with comorbid depression - a MOOD-HF substudy (2019) (0)
- Objective response and prolonged stable disease in refractory adrenocortical carcinoma treated with cabozantinib: An international case series and protocols of phase II clinical trials. (2019) (0)
- Circulating cell-free DNA-based biomarkers as a tool for disease surveillance in adrenocortical carcinoma (2021) (0)
- Correction to: Adrenocortical incidentalomas and bone: from molecular insights to clinical perspectives (2018) (0)
- Price Management for Retailers (2018) (0)
- Growing luxury brands by increasing the price: does the Veblen effect exist (2021) (0)
- Adrenalectomies in children and adolescents in Germany – a diagnose related groups based analysis from 2009-2017 (2022) (0)
- Steroidogenic factor 1 - a valuable diagnostic and prognostic tool in patients with adrenocortical carcinoma (2009) (0)
- The syndrome of inappropriate antidiuresis: a copeptin-based classification and identification of a novel subtype (2014) (0)
- Is there an epithelial to mesenchymal transition (EMT) in adrenocortical tumours? (2020) (0)
- Cytochrome P450 (CYP) 2W1 affect steroid secretion in adrenocortical cell line and tumor tissues (2020) (0)
- RNA-sequencing of adrenocortical tumors reveals novel pathogenetic insights (2020) (0)
- PF311 ISOLATED PRIMARY ADRENAL LYMPHOMA (IPAL) - AN EMERGING LYMPHOMA ENTITY? RESULTS OF A RETROSPECTIVE MULTICENTER STUDY (2019) (0)
- Consecutive development of adrenal Cushing´s syndrome and Cushing´s disease in a female patient with somatic CTNNB1, USP8, and NR3C1 mutations (0)
- Impaired blood glucose regulation during physical exercise in APS2 patients with combined Addison's disease and type 1 diabetes (2014) (0)
- Evaluation of a standardized protocol for the collection and storage of adrenal tumor samples – preparation for an international adrenal tumor bank (2006) (0)
- The new TNM classification is inferior to the Lee classification in predicting outcome in patients with adrenocortical carcinoma (2006) (0)
- Course of serum potassium levels during the hypertonic saline infusion test for diagnosis of diabetes insipidus (2020) (0)
- PRKACA mutations in adrenal Cushing can alter substrate specificity (2017) (0)
- The role of circulating and tumor infiltrating T-cells on clinical outcome in adrenocortical carcinoma (2012) (0)
- Dendritic cell based immunotherapy against adrenocortical carcinoma – screening for suitable targets (2006) (0)
- Solitary pancreatic metastasis of an adrenocortical carcinoma (2015) (0)
- Increased risk of cardiometabolic disease in patients with benign adrenal tumours with and without cortisol excess: a casecontrol study (2021) (0)
- Mild autonomous cortisol secretion portends similar cardiac compromise as overt endogenous Cushings syndrome (2022) (0)
- Mitotane directly interacts with lipid membranes and alters membrane structure and dynamics (2015) (0)
- Assessment of VAV 2 expression refines prognostic prediction � . 3 in adrenocortical carcinoma � (0)
- PRKACA L206R mutation in adrenal Cushing's syndrome makes PKA RII[beta] susceptible for caspase-mediated cleavage (2018) (0)
- Rationale and design of the cardiovascular status in patients with endogenous cortisol excess study (CV-CORT-EX): a prospective non-interventional follow-up study (2021) (0)
- Faculty Opinions recommendation of Insulin growth factor receptor (IGF-1R) antibody cixutumumab combined with the mTOR inhibitor temsirolimus in patients with metastatic adrenocortical carcinoma. (2013) (0)
- OR29-2 Mild Autonomous Cortisol Excess (MACE) in Adrenal Incidentalomas - Metabolic Risk Profile and Urinary Steroid Metabolome Analysis in 1208 Prospectively Recruited Patients (2019) (0)
- Volume-outcome relationship in adrenal surgery from 2009-2017 in Germany-a retrospective study. (2023) (0)
- Systemic treatment of advanced differentiated and medullary thyroid cancer (2015) (0)
- Targeted molecular analysis in adrenocortical carcinomas: a way towards personalized medicine (2017) (0)
- Copeptin in the differential diagnosis of the polydipsia-polyuria syndrome – revisiting the direct and indirect water deprivation tests (2010) (0)
- Effects of liraglutide plus PYY3-36 vs. Roux-en-Y gastric bypass on hypothalamic gene expression (2021) (0)
- OR25-05 Increased Overall Mortality and Cardiovascular Morbidity in Patients with Adrenal Incidentalomas and Autonomous Cortisol Secretion: Results of the ENS@T NAPACA-Outcome Study (2020) (0)
- [Non-functioning pituitary tumors - short presentation of the first German guideline]. (2020) (0)
- Effects of semaglutide, PYY3-36, antagonists of the GLP-1/NPY-Y2 receptors, and empagliflozin on non-alcoholic fatty liver disease (2023) (0)
- Customer Integration as Common Denominator of Services – Insights for Service Marketing (2005) (0)
- Adverse events associated to mitotane treatment in patients with adrenocortical carcinoma (2021) (0)
- Detection of pheochromocytoma by enzyme immunoassay measurements of plasma metanephrines requires appropriately established upper cut-offs of reference intervals (2014) (0)
- [Vitamin D - A Critical Review of Current Evidence]. (2020) (0)
- Limited weight loss with gastric banding in patients with craniopharyngeoma (2010) (0)
- BIRC7/livin, a member of inhibitor of apoptosis protein (IAP) family, in adrenocortical tumors (2014) (0)
- AKT is highly phosphorylated in pheochromocytomas, but not in adrenocortical tumors (2004) (0)
- The Population Comparison Index: An Intuitive Measure to Calibrate the Extent of Impairments in Patient Cohorts in Relation to Healthy and Diseased Populations (2023) (0)
- Ubiquitin specific peptidase 8 (USP8) in human corticotroph pituitary tumors- possible targets and mode of action (2017) (0)
- Single nucleotide polymorphism array profiling as tool to discover new candidates in diagnosis and prognosis for adrenocortical tumors (2013) (0)
- Urine steroid metabolomics as a novel diagnostic tool for recurrent adrenocortical carcinoma detection (2019) (0)
- Evaluation of a standardized protocol for the collection and storage of adrenal tumor samples preparation for an European adrenal tumor bank (ENS@T) (2006) (0)
- Running title: Bevacizumab plus capecitabine in ACC (2009) (0)
- High resolution tissue mass spectrometry imaging: a new tool for identification of prognostic markers in adrenocortical carcinoma (2017) (0)
- Abstract LB132: In silico mutant neoantigen prediction - a promising avenue for target identification in human adrenocortical carcinoma (2023) (0)
- Immunity in adrenocortical carcinoma patients - interplay between anti-cancer immunity and steroid hormones (2017) (0)
- Long-term outcome of laparoscopic versus open adrenalectomy for adrenocortical carcinoma (2009) (0)
- Arginine-stimulated copeptin measurements - a new test for diabetes insipidus (2019) (0)
- Corrigendum to "Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up": [Annals of Oncology volume 31 (2020) 1476-1490]. (2022) (0)
- [Endogenous Cushing's syndrome: new insights]. (2015) (0)
- Steroid and global metabolome in benign adrenal tumours with mild autonomous cortisol secretion: analysis by mass spectrometry and machine learning to understand metabolic risk (2022) (0)
- Osteopontin (OPN) expression in adrenocortical cancer – missing effect of OPN on proliferation in vitro and survival in vivo (2007) (0)
- SUN-LB22 PLK1 as a New Treatment Target for Adrenocortical Carcinoma (2020) (0)
- University of Birmingham Expression of SOAT1 in adrenocortical carcinoma and response to mitotane monotherapy (2020) (0)
- European Journal of Endocrinology Prize Winner (2014) (0)
- Long-Term Outcomes of Adjuvant Mitotane Therapy in Patients With Radically Adrenocortical Carcinoma (2018) (0)
- Effects of liraglutide + / - PYY3-36 vs. Roux-en-Y gastric bypass on non-alcoholic fatty liver disease (2021) (0)
- High levels of ACTH can restore adrenal morphology and function in POMC knock out mice (2005) (0)
- Is There a Role for Laparoscopic Adrenalectomy in Patients with Suspected Adrenocortical Carcinoma? A Critical Appraisal of the Literature (2013) (0)
- Survivin – a promising target for immunotherapy in patients with adrenocortical carcinoma (2007) (0)
- Germline CYP2W1*6 polymorphism is a new predictive marker of sensitivity to mitotane treatment in advanced adrenocortical carcinoma: a multicenter European study (2018) (0)
- Single nucleotide polymorphism array profiling of adrenocortical tumors: evidence for an adenoma carcinoma sequence? (2013) (0)
- Adrenal phenotype in TPIT insufficient animals cannot be restored by short-term treatment with physiological doses of ACTH and N-POMC (2005) (0)
- Effects of a combinatory treatment with semaglutide and a selective PYY-Y2 receptor analogue in diet-induced obese rats: Surpassing bariatric surgery? (#64) (2022) (0)
- Subtype differentiation in primary hyperaldosteronism: evaluation of alternative algorithms avoiding a controversial gold standard (2010) (0)
- Immune infiltrate and PD-1 / PD-L1 expression in adrenocortical carcinoma: who can predict patients´ outcome? (2020) (0)
- The brazilian Arg337His germ line hot spot mutation in exon 10 of TP53 is infrequent in german patients with adrenocortical carcinoma (2006) (0)
- Role of GLUT-2 expression and MGMT methylation for streptozotocin clinical response in adrenocortical carcinoma (2018) (0)
- Reply to Sebastien Gaujoux, Stephane Bonnet, Bertrand Dousset’s Letter to the Editor re: David Brix, Bruno Allolio, Wiebke Fenske, et al. Laparoscopic Versus Open Adrenalectomy for Adrenocortical Carcinoma: Surgical and Oncologic Outcome in 152 Patients. Eur Urol 2010;58:609–15 (2010) (0)
- Machine Learning models for the accurate prediction of malignant pheochromocytomas and paragangliomas (2022) (0)
- Update in the genetic landscape of Cushing's Disease: TP53 and a new deubiquitinase in spotlight (2018) (0)
- [123I]Iodometomidate as a radiotracer for diagnosis of adrenal tumours and adrenocortical carcinoma (2008) (0)
- University of Birmingham Alterations in protein kinase A substrate specificity as a potential cause of Cushing’s Syndrome (2019) (0)
- Metyrapone vs osilodrostat in the short-term therapy of endogenous Cushing's syndrome: results from a retrospective single center analysis (2022) (0)
- JIL-O: Establishment of a new steroidogenic human adrenocortical carcinoma cell line (2020) (0)
- [OP.3A.06] LONG TERM FOLLOW-UP IN PATIENTS OPERATED ON A PHEOCHROMOCYTOMA OR A PARAGANGLIOMA: COMPILATION OF THE ENS@T DATABASE (2016) (0)
- Diagnosis and treatment of adrenocortical carcinomas (2010) (0)
- Urine steroid metabolomics as a novel diagnostic tool for early detection of recurrence in adrenocortical carcinoma (2015) (0)
- Prognostic value of the Weiss and Wieneke(AFIP) scoring systems in pediatric ACC. (2023) (0)
- Differential mortality risk prediction by aldosterone and cortisol in systolic heart failure with versus without mineralocorticoid receptor blockade (2013) (0)
- Sunitinib decreases adrenocortical cancer cell proliferation and specifically inhibits adrenal steroidogenesis (2010) (0)
- LONG-TERM OUTCOME OF LAPAROSCOPIC VERSUS OPEN ADRENALECTOMY FOR ADRENOCORTICAL CANCER (2009) (0)
- Metastatic pheochromocytoma and paraganglioma: Somatostatin receptor 2 expression, genetics and therapeutic responses. (2023) (0)
- Prognostic factors in localized adrenocortical carcinoma (ACC) after complete resection (2008) (0)
- PLK1 inhibitors as a new targeted treatment for adrenocortical carcinoma (2021) (0)
- Urine steroid metabolome analysis allows for metabolic risk stratification in 1309 prospectively recruited patients with benign adrenal tumours and different degrees of cortisol excess (2019) (0)
- OR04-5 Circulating Cell-Free DNA-Based Biomarkers For Prognostication and Disease Surveillance in Adrenocortical Carcinoma (2022) (0)
- Efficacy and safety of radiation therapy in advanced adrenocortical carcinoma (ACC) (2021) (0)
- TP53 mutations in functional corticotroph tumors are linked to invasion and worse clinical outcome (2022) (0)
- Outcome and prognostic factors in adrenocortical cancer after complete tumor resection (2006) (0)
- Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma (2023) (0)
- Adrenal crisis in patients with primary and secondary adrenal insufficiency (2006) (0)
- Clinical relevance of targeted sequencing in paraffin-embedded samples for prognostic classification of adrenocortical carcinoma (2023) (0)
- Differences in morbidity and mortality between unilateral adrenalectomy for adrenal Cushing’s syndrome and bilateral adrenalectomy for therapy refractory extra-adrenal Cushing’s syndrome (2022) (0)
- Cardiovascular complications in CKD 5D (2012) (0)
- Inhibitor of apoptosis proteins (IAP) in adrenocortical tumors (2015) (0)
- Diagnosing Vasopressin Deficiency (Central Diabetes Insipidus) using Copeptin following Hypertonic Saline and Arginine Stimulation (2023) (0)
- Focal DNA methylation measurement in adrenocortical carcinoma is a prognostic marker independent from tumor stage and Ki67; an ENSAT study (2016) (0)
- Evaluation of hENT1 expression in adrenocortical tumors: Correlation with clinical outcome and response to gemcitabine chemotherapy (2015) (0)
- [Erratum to: Thyroid gland and the heart]. (2019) (0)
- Deficits in the clinical management of patients with adrenocortical carcinoma in Germany (2008) (0)
- 738 ONCOLOGIC OUTCOME OF LAPAROSCOPIC AND OPEN ADRENALECTOMY IN ADRENOCORTICAL CANCER: A CASE CONTROL STUDY IN 54 PATIENTS (2009) (0)
- Reduced 5α-reductase activity in peripheral blood mononuclear cells in polycystic ovarian syndrome a compensatory mechanism for androgen excess? (2007) (0)
- Chapter 107 – Adrenocortical Carcinoma (2016) (0)
- Sequential primary adrenocortical culture system for genetic transformation and adrenocortical tumorigenesis using CRISPR/Cas9-mediated genome editing (2022) (0)
- PRKACA mutations in adrenal Cushing impair association with the PKA regulatory subunit (2016) (0)
- Effects of bariatric surgery in patients with craniopharyngioma (2020) (0)
- Endogenous Cushings syndrome is associated with impaired myocardial work efficiency (2022) (0)
- Analysis: The Economics of Price (2018) (0)
- Urine steroid metabolomics as a diagnostic tool for detection of adrenocortical malignancy - a prospective test validation study (2018) (0)
- Erythropoiesis in endogenous Cushing syndrome: sex-related and subtype-specific differences (2023) (0)
- PLK1 inhibitors as potential new treatment for adrenocortical carcinoma (2019) (0)
- Treatment of refractory adrenocortical carcinoma with thalidomide: results of a retrospective analysis of 15 patients (2014) (0)
- Differential expression of the protein kinase A subunits in normal adrenal glands and adrenocortical adenomas (2017) (0)
- Bisphenols in adrenocortical cell culture: Further evidence for the relevance of endocrine disruptive chemicals for adrenal gland functionality (2023) (0)
- Fundamentals of Price Management (2018) (0)
- University of Effects of germline CYP2W1*6 and CYP2B6*6 single nucleotide polymorphisms on mitotane treatment in adrenocortical carcinoma (2020) (0)
- SUN-211 Active Steroid Hormone Synthesis Renders Adrenocortical Cells Highly Susceptible to Type II Ferroptosis Induction (2020) (0)
- Innovations in Price Management (2018) (0)
- Targeted therapy of advanced parathyroid carcinoma guided by genomic and transcriptomic profiling. (2023) (0)
- Adrenocortical carcinoma - current concepts and future perspectives (2014) (0)
- Management of adrenocorticol carcinoma: what have we learnt from recent trials? (2011) (0)
- ESE - ENSAT guidelines on the management of adrenocortical carcinoma in adults (2018) (0)
- Oxytocin levels in response to pituitary provocation tests in healthy volunteers. (2021) (0)
- Reduced androgen activation in peripheral blood mononuclear cells in polycystic ovarian syndrome – a compensatory mechanism for hyperandrogenaemia? (2007) (0)
- Inhibitor of apoptosis protein livin/BIRC7 in adrenocortical tumours (2015) (0)
- [Hormones and The Heart - Clinical Cases]. (2021) (0)
- 271 ANALYSIS OF THE FIRST 346 PATIENTS IN THE GERMAN ADRENOCORTICAL CARCINOMA REGISTRY (2007) (0)
- Effects of semaglutide, PYY3-36, and empagliflozin on the adrenal gland transcriptome in diet induced obese rats (2023) (0)
- Targeted molecular markers derived from genomic classification for adrenocortical cancer prognostication (2017) (0)
- Investigating the role of deubiquitinases in adrenocortical carcinoma (2023) (0)
- CYP2W1*6 polymorphism as a potential predictive marker of sensitivity to mitotane treatment in adrenocortical carcinoma. (2017) (0)
- Correction to: Differences in morbidity and mortality between unilateral adrenalectomy for adrenal Cushing’s syndrome and bilateral adrenalectomy for therapy refractory extra-adrenal Cushing’s syndrome (2022) (0)
- Epithelial to mesenchymal transition in adrenocortical tumours: focus on FGF-FGFR pathway and c-MET (2017) (0)
- Outcome of patients with adrenocortical cancer after discontinuation of adjuvant mitotane therapy (2017) (0)
- I-123-Iodometomidate for adrenal imaging -- First clinical experience (2007) (0)
- The role of FDG-PET in patients with adrenocortical cancer (2007) (0)
- Comparison of Metyrapone, OSilodrostat and KEToconazolE in the short-term thERapy of endogenous Cushing's syndrome: preliminary results of the MOSKETEER study (2023) (0)
- PD-1 and PD-L1 immune checkpoint expression - the prognostic impact on adrenocortical carcinoma (2022) (0)
- Pre-clinical evaluation of the multitargeted tyrosin kinase inhibitor sunitinib in the treatment of adrenocortical carcinoma (ACC) (2007) (0)
- OR03-02 Identification of a Novel Stem/Progenitor Population of the Adrenal Medulla (2020) (0)
- PRKACA L206R mutation in adrenal Cushing induces histone H1.4 hyper-phosphorylation (2018) (0)
- Impact of the chemokine receptors CXCR4 and CXCR7 on metastatic potential and survival in adrenocortical carcinoma (2016) (0)
- Plasma metabolomics profile in patients with Cushing's syndrome (2016) (0)
- Effects of a combinatory treatment with semaglutide and a NPY Y2 receptor selective PYY 3-36 analogue in diet-induced obese rats: surpassing bariatric surgery? (2023) (0)
- Questionable value of [99mTc]-sestamibi scintigraphy in patients with pHPT and negative ultrasound (2022) (0)
- [Endocrine Disrupting Chemicals]. (2022) (0)
- Faculty Opinions recommendation of Identification of a CpG island methylator phenotype in adrenocortical carcinomas. (2012) (0)
- Protein Kinase A signaling saves regulatory subunit II[beta] from PRKACA mutation-mediated degradation (2017) (0)
- Perioperative hemodynamic stability in patients with pheochromocytoma – laparoscopic vs. open surgery (2005) (0)
- Differential adrenal toxicity of SOAT1-inhibitors (2020) (0)
- Transcriptome in paraffin samples for the diagnosis and prognosis of adrenocortical carcinoma (2022) (0)
- 68 Influence of bariatric surgery on antidiabetic medications: An analysis of health insurance data in the context of the ACHT project-Obesity Care and Health Therapy (2021) (0)
- The influence of surgery in the management of recurrent adrenocortical carcinoma. (2012) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Martin Fassnacht?
Martin Fassnacht is affiliated with the following schools:
